NEJM This Week — February 26, 2026

This week, we explore a new standard of care for high-risk HER2-positive early breast cancer, long-acting therapy for people with HIV facing adherence challenges, a first-in-class trial of a p53 reactivator, and tecovirimat for mpox. We review group B streptococcal disease and a revealing case of prosthetic joint infection. Perspectives examine the role of folate therapy, Medicare drug-price negotiation, AI in medical education, and incidental findings.

You can listen to NEJM This Week — February 26, 2026 online on Radio and Podcast. Open the player on this page to stream the available audio.

NEJM This Week — February 26, 2026 is an episode from NEJM This Week - Audio Summaries by NEJM Group.

This episode is 26:58 long.

This episode was published on Feb 25, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from NEJM This Week - Audio Summaries when more episodes are available from the podcast feed.